Antimicrobial activity of human prion protein is mediated by its N-terminal region.
Pasupuleti. Mukesh M; Roupe. Markus M; Rydengård. Victoria V; Surewicz. Krystyna K; Surewicz. Witold K WK; Chalupka. Anna A; Malmsten. Martin M; Sörensen. Ole E OE; Schmidtchen. Artur A
Key Findings
- The N‑terminal region of PrP has strong antibacterial and antifungal activity.
- PrP‑derived peptides break microbial membranes similarly to LL‑37 but without forming a helix.
- PrP expression rises during skin injury, suggesting a role in wound‑site defense.
Practical Outcomes
- The study shows that membrane‑disrupting peptides are effective antimicrobials, reinforcing the idea behind using LL‑37 or similar peptides for skin health. However, it doesn’t provide new dosing or supplementation guidance for LL‑37, so biohackers should view it as mechanistic insight rather than a direct protocol upgrade.
Summary
Researchers found that the front part of the human prion protein can kill bacteria and fungi, acting much like the well‑known antimicrobial peptide LL‑37 by punching holes in cell membranes. Unlike LL‑37, these prion‑derived pieces don’t form a helix when they hit bacterial membranes, and the protein’s levels go up when skin is wounded, hinting it helps protect wounds.
Abstract
Cellular prion-related protein (PrP(c)) is a cell-surface protein that is ubiquitously expressed in the human body. The multifunctionality of PrP(c), and presence of an exposed cationic and heparin-binding N-terminus, a feature characterizing many antimicrobial peptides, made us hypothesize that PrP(c) could exert antimicrobial activity. Intact recombinant PrP exerted antibacterial and antifungal effects at normal and low pH. Studies employing recombinant PrP and N- and C-terminally truncated variants, as well as overlapping peptide 20mers, demonstrated that the antimicrobial activity is mediated by the unstructured N-terminal part of the protein. Synthetic peptides of the N-terminus of PrP killed the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa, and the Gram-positive Bacillus subtilis and Staphylococcus aureus, as well as the fungus Candida parapsilosis. Fluorescence studies of peptide-treated bacteria, paired with analysis of peptide effects on liposomes, showed that the peptides exerted membrane-breaking effects similar to those seen after treatment with the "classical" human antimicrobial peptide LL-37. In contrast to LL-37, however, no marked helix induction was detected for the PrP-derived peptides in presence of negatively charged (bacteria-mimicking) liposomes. PrP furthermore showed an inducible expression during wounding of human skin ex vivo and in vivo, as well as stimulation of keratinocytes with TGF-alpha in vitro. The demonstration of an antimicrobial activity of PrP, localisation of its activity to the N-terminal and heparin-binding region, combined with results showing an increased expression of PrP during wounding, indicate that PrPs could have a previously undisclosed role in host defense.
Study Information
pubmed
2009
2009-10-07T00:00:00.000Z
10.1371/journal.pone.0007358
86
59